[Portfolio]

Drugs

Companies

We focus on biomedical technology companies developing next-generation drugs, devices and diagnostics, data, tools, and healthcare services and work closely with each portfolio company to build and grow the business from inception to exit.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Affini-T
Private Equity
Co-Investments
Drugs
Private
No
US
Alentis Therapeutics
Private Equity
Drugs
Private
No
Non-Us
Anagenex
Private Equity
Drugs
Private
No
US
ArriVent
IPO in 2024
Private Equity
Drugs
Public
No
US
Ashvattha Therapeutics
Exit in 2019
Private Equity
Drugs
Exited
No
US
Atai Life Sciences
IPO in 2021
Private Equity
Co-Investments
Drugs
Public
No
Non-Us
Avalyn Pharma
Private Equity
Drugs
Private
No
US
Aviceda Therapeutics
Private Equity
Drugs
Private
No
US
Boost Neuroscience
M&A in 2025
Private Equity
Drugs
Exited
No
US
Cage Pharmaceuticals
Private Equity
Co-Investments
Drugs
Private
Yes
US
Cambrian Biopharma
Private Equity
Drugs
Private
No
US
Cartography
Private Equity
Drugs
Private
No
US
Centenara Labs (formerly Rejuveron)
Private Equity
Drugs
Private
No
Non-Us
Character Biosciences
Private Equity
Drugs
Private
No
US
Clasp Therapeutics
Private Equity
Co-Investments
Drugs
Private
Yes
US
Compass Pathways
IPO in 2020
Private Equity
Drugs
Public
No
Non-Us
Dianthus
IPO in 2024
Private Equity
Drugs
Public
No
US
Elektrofi
Private Equity
Drugs
Private
No
US
Ensoma
Loan Repayment in 2024
Private Equity
Structured Opportunities
Drugs
Exited
No
US
Enveda
Private Equity
Drugs
Private
No
US
Faze Medicines
Private Equity
Drugs
Private
No
US
Georgiamune
Private Equity
Drugs
Private
No
US
GlycoEra
Private Equity
Drugs
Private
No
Non-Us
Iambic
Private Equity
Drugs
Private
No
US
Imbria
Private Equity
Drugs
Private
No
US
Lassen Therapeutics
Private Equity
Drugs
Private
No
US
Metagenomi
IPO in 2024
Private Equity
Drugs
Public
No
US
Neumora Therapeutics
IPO in 2023
Private Equity
Drugs
Public
No
US
NextPoint Therapeutics
Private Equity
Drugs
Private
No
US
Octant Bio
Private Equity
Co-Investments
Drugs
Private
No
US
Odyssey Therapeutics
Private Equity
Drugs
Private
No
US
OnCusp Therapeutics
Private Equity
Drugs
Private
No
US
Orasis Pharmaceuticals
Structured Opportunities
Drugs
Private
No
Non-Us
Orpheris
Exit in 2021
Private Equity
Drugs
Exited
No
US
Parabilis Medicines (formerly FogPharma)
Private Equity
Drugs
Private
No
US
Perceive Biotherapeutics
Private Equity
Drugs
Private
No
US
Perfuse Therapeutics
Private Equity
Drugs
Private
No
US
Pheast Therapeutics
Private Equity
Co-Investments
Drugs
Private
Yes
US
Port Therapeutics
Private Equity
Drugs
Private
No
US
Protara Therapeutics
Private Equity
Drugs
Private
No
US
Recognify Life Sciences
Private Equity
Drugs
Private
No
US
STAR Therapeutics
Private Equity
Drugs
Private
No
US
Satellite Bio
Private Equity
Drugs
Private
No
US
Sensei Bio
IPO in 2021
Private Equity
Drugs
Public
No
US
Septerna
IPO in 2024
Private Equity
Drugs
Public
No
US
Spiral Therapeutics
Private Equity
Drugs
Private
No
US
Volastra Therapeutics
Private Equity
Drugs
Private
No
US
WindMIL Therapeutics
Private Equity
Drugs
Private
No
US
eGenesis
Private Equity
Drugs
Private
No
US